Anti-prolactin autoantibodies were also identified in SLE patients, considering that all SLE patients with anti-PRL autoantibodies had hyperprolactinemia (hPRL) and only 31.7% of SLE patients classified with idiopathic hPRL had anti-prolactin antibodies. The gene discussed is PRL; the disease is systemic lupus erythematosus.